Cargando…

EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer

The cancer metastasis process involves dysregulated oncogenic kinase signaling, but how this orchestrates metabolic networks and signal cascades to promote metastasis is largely unclear. Here we report that inhibition of glutamate dehydrogenase 1 (GDH1) and ribosomal S6 kinase 2 (RSK2) synergistical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, JiHoon, Chun, Jaemoo, Hwang, Jung Seok, Pan, Chaoyun, Li, Jie, Boese, Austin C., Young, Isabelle, Malin, Courteney M., Kang, Yibin, Gibbons, Don L., Sica, Gabriel, Fu, Haian, Ramalingam, Suresh S., Jin, Lingtao, Kang, Sumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813823/ https://www.ncbi.nlm.nih.gov/pubmed/36516759 http://dx.doi.org/10.1016/j.celrep.2022.111827

Ejemplares similares

Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis
por: Boese, Austin C., et al.
Publicado: (2023)

EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
por: Linder, Markus, et al.
Publicado: (2018)

Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
por: Pan, Chaoyun, et al.
Publicado: (2021)

Tauroursodeoxycholic Acid Enhances Osteogenic Differentiation through EGFR/p-Akt/CREB1 Pathway in Mesenchymal Stem Cells
por: Kang, Hyojin, et al.
Publicado: (2023)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

Epigenetic activation of secretory phenotypes in senescence by the FOXQ1-SIRT4-GDH signaling
por: Sun, Xinpei, et al.
Publicado: (2023)

EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer
por: Hong, Sook-hee, et al.
Publicado: (2022)

Mitochondrial metabolism-mediated redox regulation in cancer progression
por: Boese, Austin C., et al.
Publicado: (2021)

Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
por: Kuo, Macus Tien, et al.
Publicado: (2019)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Recruitment and Activation of RSK2 by HIV-1 Tat
por: Hetzer, Claudia, et al.
Publicado: (2007)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations
por: Shi, Puyu, et al.
Publicado: (2019)

EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
por: Zhang, Xuedi, et al.
Publicado: (2022)

Tyrosine kinase receptor RON activates MAPK/RSK/CREB signal pathway to enhance CXCR4 expression and promote cell migration and invasion in bladder cancer
por: Chen, Junfeng, et al.
Publicado: (2022)

Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
por: Della Corte, Carminia Maria, et al.
Publicado: (2017)

MI.D.AS.: a forward detector for the GDH experiment at Mainz
por: Altieri, S, et al.
Publicado: (1998)

Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo
por: Girinathan, Brintha Parasumanna, et al.
Publicado: (2016)

The pleiotropic effects of the glutamate dehydrogenase (GDH) pathway in Saccharomyces cerevisiae
por: Mara, P., et al.
Publicado: (2018)

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status
por: Rego, R L, et al.
Publicado: (2010)

Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity
por: Koizumi, Yukio, et al.
Publicado: (2018)

Activation of RSK by phosphomimetic substitution in the activation loop is prevented by structural constraints
por: Somale, Desiana, et al.
Publicado: (2020)

Frequent activation of EGFR in advanced chordomas
por: Dewaele, Barbara, et al.
Publicado: (2011)

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
por: Corte, Carminia Maria Della, et al.
Publicado: (2022)

Correction: Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo
por: Girinathan, Brintha Parasumanna, et al.
Publicado: (2016)

Dracohodin Perochlorate Stimulates Fibroblast Proliferation via EGFR Activation and Downstream ERK/CREB and PI3K/Akt/mTOR Pathways In Vitro
por: Liu, Lin, et al.
Publicado: (2019)

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
por: Zang, Hongjing, et al.
Publicado: (2020)

Genetic variant rs10251977 (G>A) in EGFR-AS1 modulates the expression of EGFR isoforms A and D
por: Dhamodharan, Shankar, et al.
Publicado: (2021)

Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway
por: Li, Shuai, et al.
Publicado: (2021)

rSK1 in Rat Neurons: A Controller of Membrane rSK2?
por: Autuori, Eleonora, et al.
Publicado: (2019)

Arsenic Activates EGFR Pathway Signaling in the Lung
por: Andrew, Angeline S., et al.
Publicado: (2009)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
por: Skrzypski, Marcin, et al.
Publicado: (2017)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
por: Hackner, Klaus, et al.
Publicado: (2021)

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
por: Bae, Kieun, et al.
Publicado: (2022)

Corrigendum to “Dracohodin Perochlorate Stimulates Fibroblast Proliferation via EGFR Activation and Downstream ERK/CREB and PI3K/Akt/mTOR Pathways In Vitro”
por: Liu, Lin, et al.
Publicado: (2020)

Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT
por: Jin, Yujin, et al.
Publicado: (2019)

EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
por: Jung, Minkyu, et al.
Publicado: (2012)

Bioinformatics based structural characterization of glucose dehydrogenase (gdh) gene and growth promoting activity of Leclercia sp. QAU-66
por: Naveed, Muhammad, et al.
Publicado: (2014)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
por: Yang, Won Seok, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f14p57t3i0jc9bh9r4vqich52q